drugset / Trial / NCT01481831
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting
Phase 4
Completed
599 enrolled
Shanghai Changzheng Hospital
JiangSu Chia-Tai Tianqin Pharmacy Co.Ltd · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This purpose of this study is to evaluate the efficacy and safety of single and repeated doses of palonosetron hydrochloride in preventing nausea and vomiting caused by moderate and highly emetogenic chemotherapy in patients.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Palonosetron | Other / unclassified | 0.25 mg | Intravenous |